Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech cash
Cash and short-term investments held at the end of each period.
Alvotech's cash was $142.75M at Jun 30, 2026. For fiscal 2025 it was $172.36M, up 235.1% from the year before. The highest annual figure on record is $172.36M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $172.36M | +235.1% |
| FY2024 | Dec 31, 2024 | $51.43M | +360.9% |
| FY2023 | Dec 31, 2023 | $11.16M | -83.2% |
| FY2022 | Dec 31, 2022 | $66.43M | +278.4% |
| FY2021 | Dec 31, 2021 | $17.56M | -44.6% |
| FY2020 | Dec 31, 2020 | $31.69M | -53.0% |
| FY2019 | Dec 31, 2019 | $67.40M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $142.75M | +1204.4% |
| Q4 FY2025 | Dec 31, 2025 | $172.36M | +1444.9% |
| Q2 FY2025 | Jun 30, 2025 | $151.45M | +150.5% |
| Q4 FY2024 | Dec 31, 2024 | $51.43M | -22.6% |
| Q2 FY2024 | Jun 30, 2024 | $10.94M | -91.5% |
| Q4 FY2023 | Dec 31, 2023 | $11.16M | -36.4% |
| Q2 FY2023 | Jun 30, 2023 | $60.47M | +90.8% |
| Q4 FY2022 | Dec 31, 2022 | $66.43M | -1.4% |
| Q2 FY2022 | Jun 30, 2022 | $128.44M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.56M | – |
| Q4 FY2020 | Dec 31, 2020 | $31.69M | – |
| Q4 FY2019 | Dec 31, 2019 | $67.40M | – |
See a number that looks wrong?